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Background: The objective of this study is the effectiveness of multidisciplinary rehabilitation on treatment-related adverse effects
after completed radiotherapy in patients with prostate cancer (PCa).
Methods: In a single-centre oncology unit in Odense, Denmark, 161 PCa patients treated with radiotherapy and androgen
deprivation therapy were randomly assigned to either a programme of two nursing counselling sessions and two instructive
sessions with a physical therapist (n¼ 79) or to usual care (n¼ 82). Primary outcome was Expanded Prostate Cancer Index
Composite (EPIC-26) urinary irritative sum-score. Before radiotherapy, pre-intervention 4 weeks after radiotherapy, and after a
20-week intervention, measurements included self-reported disease-specific quality of life (QoL; EPIC-26, including urinary, bowel,
sexual, and hormonal symptoms), general QoL (Short-form-12, SF-12), pelvic floor muscle strength (Modified Oxford Scale), and
pelvic floor electromyography. Intension-to-treat analyses were made with adjusted linear regression.
Results: The intervention improved, as compared with controls, urinary irritative sum-score 5.8 point (Cohen’s d¼ 0.40; P¼ 0.011),
urinary sum-score (d¼ 0.34; P¼ 0.023), hormonal sum-score (d¼ 0.19; P¼ 0.018), and the SF-12 Physical Component Summary,
d¼ 0.35; P¼ 0.002. Patients with more severe impairment gained most. Pelvic floor muscle strength measured
by electromyography declined in both groups, P¼ 0.0001.
Conclusion: Multidisciplinary rehabilitation in irradiated PCa patients improved urinary and hormonal symptoms, and
SF-12 physical QoL.
Prostate cancer (PCa) is the most frequent male malignancy in the
Western world (Ferlay et al, 2010). The development of treatment
with radiotherapy combined with androgen deprivation therapy
(ADT) has, in locally advanced or high-risk PCa, increased the
10-year survival rates from B60% to 470% (Widmark et al,
2009). Following these improvements in survival, a growing
interest has emerged in evaluating the impact of the overall
treatment on quality of life (QoL) (Miller et al, 2005; Sanda et al,
2008), and clinical attention has been directed towards how the
adverse effects of the treatment may be counteracted (Johansen,
2007; Armes et al, 2009; World Health Organization, 2012).
Adverse effects are categorised into acute disorders occurring
within 6 months of radiotherapy or late complications after
6 months or more (Grise and Thurman, 2001).
In particular, urinary irritative problems causing frequency,
nocturia, urgency or urge incontinence are of major concern
for these patients (Michaelson et al, 2008; Budaus et al, 2012).
The incidence of acute urinary tract symptoms after
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intensity-modulated radiotherapy is estimated to occur in one
or even two out of every four patients (Budaus et al, 2012).
Furthermore, the risk of late urinary adverse effects is increasing in
patients with acute disorders. In a follow-up study from the United
States of America with 1571 patients who experienced
acute urinary symptoms during treatment, the risk of having
grade 2 (CTC 3.0) late adverse effects after 10 years was
found to be significantly increased from 12 to 35% (Zelefsky
et al, 2008).
In randomised trials, home-based training of pelvic floor
exercises has been confirmed as an effective non-invasive
treatment of post-prostatectomy incontinence, showing signifi-
cantly decreased duration and degree of incontinence (Van
Kampen et al, 2000; Filocamo et al, 2005). However, this concept
has not been investigated in a randomised designed study following
treatment of PCa with radiotherapy and ADT (Cockle-Hearne and
Faithfull, 2010), and especially not with urinary irritative problems
as the primary end point. Here, we present data from the first RCT
to investigate a multidisciplinary rehabilitation programme
comparing usual care with psychosocial support from nurses and
counselling in pelvic floor exercises primarily to reduce urinary
irritative problems and secondarily to increase overall QoL.
MATERIALS AND METHODS
Setting and participation. The study called RePCa was approved
by the local Scientific Research Ethics Committee (File no.
S-20090142), the Danish National Data Protection Agency (File
no. 2012-41-1175), and registered by ClinicalTrials.gov (Study
number, NCT01272648). All participants provided written
informed consent.
Design. The design was organised as a two-armed randomised,
controlled trial recruiting from 226 patients referred to curative
radiotherapy from 1 February 2010 to 31 January 2012 at Odense
University Hospital, Denmark. A total of 209 patients fulfilled the
inclusion criteria and were eligible for participation as shown in the
CONSORT diagram (Boutron et al, 2008), Figure 1. The patients
were informed about the RePCa study from a project nurse at the
first meeting at the Department of Oncology.
Inclusion criteria: men X18 years old with biopsy-documented
adenocarcinoma of the prostate.
Exclusion criteria: former prostatectomy, not able to speak Danish,
or included in other protocols.
Information about Gleason score, TNM-staging, prostate-
specific antigen values, and comorbidity was obtained from the
medical records, and patients were registered in risk groups as
described by D’amico et al (1998) with regard to determining the
treatment plan.
Intensity-modulated radiotherapy used a prescription dose of
78Gy in 39 fractions given in five fractions per week. Inter-
fractional prostate displacement was corrected by daily IGRT using
implanted gold markers. Target volume was the prostate gland
including the proximal 2 cm of the seminal vesicles in high-risk
patients and adding a 7-mm margin. Three patients in each
randomisation group received pelvic radiotherapy due to meta-
static lymph nodes. Androgen deprivation therapy was started 3
months before radiotherapy; in T3 patients, ADT is given for up to
3 years.
Patients were randomly assigned to the intervention group or
usual care (control group) in a ratio of 1 : 1 after the completion of
radiotherapy. The randomisations were externally handled by the
Department of Clinical Research at Odense University Hospital,
Denmark, and the allocation sequence was concealed from the
research team.
Intervention. The intervention was based on the following
definition: ‘Rehabilitation is a focused and temporary process of
cooperation between the patient, relatives, and the professionals.
The purpose for the patient is to achieve an independent and
meaningful life, even if he has, or is at risk of a significant decline
in his physical, mental, or social functions. Rehabilitation is based
on the patient’s whole life situation and consists of a coordinated,
interconnected, and knowledge-based effort’ (Rehabiliteringsforum,
2004).
The intervention took place in an outpatient setting at the
Department of Oncology and the Department of Rehabilitation.
At 4 weeks post radiation, pre-intervention data were obtained
from all patients in the study and the intervention was initiated.
The control group received usual care during follow-up. The
usual care consisted of one physician visit 4 weeks after
radiotherapy. No systematic education for the control group was
provided during the trajectory. In addition to usual care, the
patients in the intervention group were instructed in an
individually suited multidisciplinary programme during two
nursing counselling sessions and during two additional sessions
of counselling by physical therapists aiming the exact need of each
individual patient; Figure 2. The patient was recommended to
bring his spouse along for all counselling and instructions in order
to increase understanding of and compliance with the exercises
suggested.
The above-mentioned intervention was provided by dedicated
staff members at each site. The seven project oncology nurses
engaged in the intervention activities were specially trained and
qualified radiation therapists, and the two physical therapists had
more than 10 years of clinical experience in the instruction and
1  Former prostatectomy
7  Other reasons
6  Treatment elsewhere
79 Allocated to intervention
2 Dropouts
from
intervention
18  No energy
13  Long transport
3   Comorbidity
4   No interest
4   Other
6   Unspecified
76 Intervention patients returned
questionnaire (8 patients partly
completed intervention)
77 Control patients returned
questionnaire
153 For final assessment
226 
Assessed for eligibility 
2 Lost to follow-
up
1 died
2 Dropouts
from control
82 Allocated to control
161 Randomised
Pre-intervention assessment
48  Refused to participate:
209
Primary assessment
3  Does not speak  Danish 
17 Excluded:
1 Lost to
follow-up
Figure 1. CONSORT-Flow chart. .
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training of men in order to address incontinence, including pelvic
floor training. This group of nine staff members were all enrolled
in a 6-day course with seven 45min lectures per day containing the
topics PCa and treatment, the male perspective, incontinence and
the pelvic floor, sexuality, depression and fear of recurrence, social
support, and finally the method of motivational interviewing
(Miller and Rollnick, 2002) that was used as a communicative
platform. To ensure consistency in the intervention, the staff had
12 supportive, 60-min reinforcing sessions every second month
provided by a motivational interview trainer. Communication
between the multidisciplinary staff members was provided during
structured documentation in the patients files.
Nursing counselling. The nursing counselling sought to provide
psychological support and enable identification of problems
regarding the disease experienced by the patient and his spouse,
Figure 2. In accordance with the framework for nursing (Benner
and Wrubel, 1989), the nurses initiated the dialogue based on the
patients needs. With this approach and secondarily with the
professional knowledge of possible themes important for PCa
patients written in a guideline, the nurses identified information
needs about adverse effects, established an individual rehabilitation
plan based on the patients’ personal goals, and, if needed, provided
advice on lifestyle changes concerning smoking, alcohol, general
fitness, diet, weight control, and further suggested solutions to
other problems, for example, toilet habits, sexuality, and psycho-
logical problems. The project oncology nurses had the authority to
refer patients in the intervention group to medical specialists,
public/community rehabilitation centres, sexologists, and social
workers.
Physical therapy counselling. The physical therapy identified the
individual patient’s need for increased pelvic floor muscle function
and general physical activity level; Figure 2. Symptoms related to
pelvic floor muscle function were explored, for example, urination
control, flatulence, and defecation. If necessary, the patient was
guided by biofeedback, a visual signal presenting the pelvic floor
strength to the patient (Dorey, 2006).
Time line Intervention group Control group
Radiotherapy
Outcome questionnaires were received by mail.
Notes:
12 Weeks before
radiotherapy
Primary assessment with questionnaires and test of
muscle strength by blinded assessors.
Randomisation
21–22 Weeks from pre-
intervention
20 Weeks from pre-
intervention
8 Weeks from pre-
intervention
Pre-intervention
4 weeks after radiotherapy
ba ba
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25-Min follow-up visit at the Department of Oncology with oncologist. Pre-intervention
questionnaires were received and checked by nurse. Patients were informed about
group allocation.
30-Min muscle strength test by blinded assessors.
60-Min first individual visit with the physical therapist. Guidance of functional home
training and pelvic floor exercises depending on the muscle strength test. A pamphlet with
the individual training goals was handed out.
40-Min first individual visit with the oncology nurse, identifying patient’s needs and
response to them, for example psychological support, counselling about lifestyle,
toilet habits, sexual problems.
45-Min second individual visit with the same physical therapist. Follow-up guidance.
40-Min second individual visit with the same oncology nurse. Follow-up and
perspectives on the new everyday life.
30-Min muscle strength test by blinded assessors.
The last questionnaire was handed out with a pre-paid envelope, and the patient was
asked to send it in within a few weeks.
Figure 2. Graphical depiction of the intervention in a randomised rehabilitation study with 161 participants with PCa, Odense,
Denmark. .
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A written pamphlet was created specifically for the purpose of
this study and explained how PCa treatment affects physical and
general health. The self-training home programme consisted of
pelvic floor muscle exercises integrated in daily activities, for
example, during driving the car, walking, or working in the garden.
The exercises for the major muscle groups included muscle
endurance and strength and balance exercises, for example, three
sessions of 10–12 repetitions for each muscle group. General
physical activities were recommended to inactive patients for at
least 30min per day. The agreement about the self-training
programme was noted in the pamphlet. The second session was
used as a follow-up on the individual goals of each patient.
Primary and secondary outcome measures. Study outcomes were
preliminary assessed before radiotherapy, as pre-intervention
measurements at 4 weeks post radiation and after the 20 weeks
of intervention; Figure 2. The 20 weeks of intervention were used
to allow for muscle training and a change from ‘being a patient’ to
‘being a cancer survivor’.
The primary outcome was defined as the urinary irritative sum-
score based on the Expanded Prostate Cancer Index Composite
(EPIC-26). The irritative sum-score was derived from four items
regarding pain, bleeding, weak stream, or frequent urination.
Secondary outcomes included QoL arising from the Medical
Outcome Study Short-form-12 (SF-12), urinary incontinence,
bowel, sexual and hormonal sum-scores as measured by the
EPIC-26, and assessment of the pelvic floor by clinical examination
and electromyography.
EPIC-26. The disease-specific validated EPIC-26 consists of
domains concerning urinary symptoms, bowel symptoms, sexual
function, and symptoms related to ADT. The internal consistency
and test-retest reliability for EPIC-26 (Cronbach’s alpha40.70 and
r40.69) for all domains support its validity. For each domain, a
sum-score is constructed. In addition, two urinary scales that
distinguish irritative/obstructive symptoms and incontinence were
obtained. For the primary outcome, the urinary irritative sum-
score, Cronbach’s alpha was 0.74 and r 40.80 (Szymanski et al,
2010). Expanded Prostate Cancer Index Composite items are
answered on a 5-point Likert scale from no problems to severe
problems. Scores are transformed linearly to a scale of 0–100, with
higher scores indicating better QoL (Wei et al, 2000; Szymanski
et al, 2010). A low inter-scale correlation observed between SF-12
and EPIC domains supports the concurrent use of EPIC with SF-12
(Wei et al, 2000).
SF-12. The generic extensively validated QoL questionnaire SF-12
(Ware et al, 1996) includes eight concepts: physical functioning,
role limitations due to physical health problems, body pain, general
health, vitality, social functioning, role limitations due to emotional
problems, and mental health. The reliability of SF-12 was tested in
two data sets and showed a test-retest summary measure of 0.89 in
the United States of America and 0.86 in the United Kingdom.
Results are expressed in two meta-scores: the Physical Component
Summary and the Mental Component Summary. These
meta-scores are standardised to the population normative values
of the United States of America, with a mean score of 50 and a s.d.
of 10. Higher scores represent better health (Ware et al, 1996).
Pelvic floor assessment. A standardised protocol ensuring a
correct and reproducible technique was used for all tests.
This protocol was developed after pilot tests of seven patients,
including subject lateral positioning, exact wording of instructions,
and avoidance of muscles other than the pelvic floor. Pilot test data
were not included in this study.
In all patients, a correct pelvic floor muscle contraction was
confirmed on digital rectal evaluation by the assessor before
making the test. The instruction used for each contraction was
‘squeeze and lift’ the pelvic floor. Muscle strength was measured by
the ability to contract. Digital evaluation was done according to the
modified 6-point Oxford Scale (Dorey, 2007). Surface anal
electromyography (EMG) was performed with NeuroTrac Myo-
Plus (Verity Medical Ltd., Hampshire, England) with an Anuform
analprobe (Patterson Medical UK Ltd, Nottinghamshire, UK). The
three assessors of the pelvic floor function were blinded and
independent of the research team. The patients were told not to
give the assessors information about group assignments.
All data entry was done by the first author. A quality control
was made with the procedure as recommended by King and
Lashley: the first 10 questionnaires in the data set were controlled,
and then every 10 questionnaire until errors occurred. Further,
each questionnaire was controlled until 10 were without errors
(King and Lashley, 2000).
Sample size calculation and statistical analyses. The power
calculation was based on a two-sided t-test on difference between
programs in the mean reduction in the EPIC-26 urinary irritative
sum-score (Michigan, 2012) corresponding to a Cohens d of 0.5
(mean change divided by s.d.). We applied a significance level of
5% and power of 80%. The sample size of 160 patients was found
by taking into account a maximal drop-out rate of 20%.
Socio-demographic and clinical characteristics were described
using means for continuous variables and frequencies for
categorical variables. Differences regarding disease-specific and
general QoL (continuous) between intervention and control groups
were tested with multiple linear regression models adjusted for pre-
intervention scores. Differences in the strength of pelvic floor
muscles were tested with the Wilcoxon rank-sum test. Inter-rater
reliability between assessors was tested in a random example of
15 records with Kappa statistics. Groups were analysed with
intention-to-treat according to the allocated group.
Correlations between variables were tested with linear regres-
sion models. We checked the model assumptions, that is, linearity,
normality, homogeneity, and serial correlation of residuals, by
relevant scatter plots followed by visual inspection.
As only one primary end point was selected and secondary end
points have to be tested in future studies, adjustments for multiple
comparisons were not made. P-values o0.05 were considered
statistically significant and were reported two-sided.
In some of the returned questionnaires, data were missing.
According to the methods described for EPIC urinary irritative
sum-score and incontinence sum-score and SF-12, all questions
should be answered to be analysed. Questionnaires with insufficient
data were therefore removed from the analysis. The EPIC domains:
urinary, bowel, sexual, and hormonal sum-scores allow one missing
answer (Ware et al, 1996; Wei et al, 2000). Statistics were calculated
with STATA 11 (StataCorp LP, College Station, TX, USA).
RESULTS
A number of 226 patients were screened for eligibility, but 48 patients
refused to participate because of several reasons; Figure 1. Groups
were balanced at pre-intervention, and we had some information of
the patients who refused; Table 1. Patient flow before and after
randomisation of 161 patients is shown in Figure 1, leaving 153
patients (95%) for the analysis. The attrition rate was 5% as four
patients dropped out, one died, and three were lost to follow-up.
A total of 71 out of 79 patients in the intervention group (90%)
completed the entire intervention programme that included two
nursing counselling and two physical therapy counselling sessions,
but data from all patients were analysed according to the allocated
group. Data (150 out of 153; 98%) regarding the primary end point
urinary irritative symptoms were completed.
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Table 1. Socio-demographic and biological pre-intervention characteristics of 161 participants and 48 refusers with primary prostate cancer included in a
randomised controlled trial after radiotherapy and androgen deprivation therapy, 2010–2012 Odense, Denmark
Intervention group (n¼79) Control group (n¼82) Refusers (n¼48)
Socio demographic characteristics
Age at first radiotherapy date (years), mean (s.d.) 68.2 (4.8) 69.0 (5.2) 68.7 (6.4)
Weight (kilo) reported at pre-intervention mean (s.d.) 84.7 (12.7) 86.3 (14.8) 85.9 (15.6)
Unknown 1 3 7
Body mass index (BMI) kgm2 mean (s.d.) 27.1 (3.6) 27.4 (4.1) 27.2 (4.6)
Unknown 1 3 7
Social status reported at pre-intervention
Living alone 10 (13%) 12 (15%) 8 (19%)
Living with a spouse 68 (87%) 67 (85%) 33 (81%)
Unknown 1 3 7
Education (years)
9–10 31 (40%) 36 (46%) 21 (52%)
12–13 24 (31%) 23 (29%) 12 (30%)
13–16 18 (23%) 18 (23%) 6 (15%)
18–20 5 (6%) 2 (2%) 1 (3%)
Unknown 1 3 8
Smoking status at pre-intervention
Never smoker 33 (42%) 32 (41%) 12 (29%)
Past smoker 30 (39%) 35 (44%) 20 (49%)
Current smoker 15 (19%) 12 (15%) 9 (22%)
Unknown 1 3 7
Medical characteristics
PSA pre-treatment serum mean ngml1 (s.d.) 21.5 (17.7) 19.8 (16.8) 21.6 (18.4)
Gleason score
o7 10 (13%) 17 (21%) 10 (21%)
7 47 (59%) 44 (54%) 25 (52%)
47 22 (28%) 21 (25%) 13 (27%)
Degree of malignancy
T1 8 (10%) 9 (11%) 6 (12%)
T2 34 (44%) 35 (43%) 23 (48%)
T3 36 (46%) 38 (46%) 19 (40%)
Unknown 1
Risk group
Low 1 (1%) 3 (4%) 6 (12%)a
Intermediate 19 (24%) 13 (16%) 8 (17%)
High 59 (75%) 65 (80%) 34 (71%)
Unknown 1
Hormone therapy
No 3 (4%) 2 (3%) 5 (11%)b
Androgen deprivation therapy (ADT) 76 (96%) 79 (97%) 42 (89%)
Unknown 1 1
Patient-reported comorbidity at pre-intervention
Charlson index score 1 20 (25%) 19 (23%) 13 (27%)
Score 2 4 (5%) 5 (6%) 1 (2%)
Score 3 0 0 0
Score 6 0 0 0
Abbreviation: PSA¼prostate-specific antigen values.
aFisher’s exact test P¼ 0.028
bFisher’s exact test P¼ 0.049
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Multiple linear regression adjusted for pre-intervention scores
showed that PCa patients in the intervention group benefitted
significantly with regard to urinary irritative symptoms with 5.8
point, Cohen’s d¼ 0.40; P¼ 0.011 (Tables 2 and 3 and Figure 3).
No significant interactions between groups and pre-intervention
scores were seen. Covariates (age, body mass index, risk group,
prostate-specific antigen values, education, smoking, and marital
status) showed no significant correlation with the urinary irritative
sum-score.
Physical Component Summary and Mental Component Sum-
mary correlated with improved urinary irritative sum-score,
r¼ 0.55; P¼ 0.015 and r¼ 0.58; Po0.001, respectively.
Subanalysis showed that the improvement of the urinary
sum-score was most pronounced in patients living alone (12.0
point, d¼ 0.83; P¼ 0.021), that pre-intervention urinary bother
(score 43) indicating moderate-to-severe problems gained
(13.1 point, d¼ 0.90; P¼ 0.034), and a pre-intervention urinary
irritative sum-score below the study mean value of 68 point
predicted a higher intervention effect with (10.1 point, d¼ 0.70;
P¼ 0.031). Urinary sum-score, hormonal sum-score, and physical
QoL (Physical Component Summary) improved significantly in
the intervention group compared with controls, whereas pelvic
floor muscle strength measured by digital evaluation (Modified
Oxford Scale 0–6) did not change significantly during the study
period at post intervention in the intervention and the control
groups, Table 4. Muscle strength measured by EMG declined
Table 2.Mean changes in QoL scores among 161 Danish prostate cancer
survivors included in a randomised rehabilitation study, Odense,
Denmark
Effect
(coefficient)a CI (95%) Pb
Intervention group vs control group
SF-12
Physical QoL (PCS) 3.6 1.3; 5.8 0.002
Mental QoL (MCS) 0.7 1.6; 3.0 0.549
EPIC domains
Urinary 4.5 0.6; 8.4 0.023
Incontinence 2.6 1.8; 6.9 0.242
Irritative 5.8c 1.4; 10.3 0.011
Bowel 3.0 1.9; 8.0 0.224
Sexual 3.6 0.9; 8.0 0.117
Hormonal 4.8 0.8; 8.8 0.018
Abbreviations: CI¼ 95% confidence interval; EPIC¼Expanded Prostate Cancer Index
Composite; MCS¼Mental Component Summary; PCS¼Physical Component Summary;
QoL¼quality of life.
aMultiple linear regression analysis adjusted for pre-intervention scores.
bReported P-values are two-sided and Po0.05 was considered statistically significant.
cExample: if the patient is in the intervention group, his mean QoL score (0–100 scale)
regarding urinary irritative sum-score increases with 5.8 point compared with the controls.
Table 3. Pre-intervention level and changes in disease-specific QoL scores (EPIC), and general QoL scores (SF-12) in intervention and control groups at 4
weeks (pre-intervention) and 24 weeks after radiotherapy (post intervention) among 161 survivors with primary prostate cancer included in (RePCa) a
prospective randomised rehabilitation study, 2010–2012 Odense, Denmark
EPIC and SF-12 mean QoL (score 0–100)a
Intervention group, n¼79 Control group, n¼82
QoL Pre-intervention Difference at 6 months Pre-intervention Difference at 6 months
Mean (s.d.) 4 Weeks after radiotherapy Between follow-up and
pre-intervention
4 Weeks after radiotherapy Between follow-up and
pre-intervention
Cohen’s db
EPIC domain
Urinary irritative 67.7 (18.7) 17.6 (18.1) 68.1 (18.7) 11.6 (16.5) 0.40
Urinary incontinence 82.5 (17.5) 7.3 (14.9) 82.2 (21.7) 4.9 (15.8)
Urinary sum-score 73.5 (14.5) 13.3 (13.9) 73.1 (17.4) 9.0 (12.9) 0.34
Bowel sum-score 77.6 (19.9) 9.7 (20.3) 77.0 (20.0) 7.6 (16.4)
Sexual sum-score 15.0 (19.5)  1.3 (13.7) 14.0 (20.1) 4,1 (16.4)
Hormonal sum-score 71.6 (18.8) 2.3 (13.2) 72.8 (18.9) 2.8 (12.8) 0.19
SF-12 domain
PCS 47.4 (8.3) 1.9 (6.7) 47.5 (9.0) 1.7 (7.9) 0.35
MCS 53.0 (8.7) 2.3 (7.1) 51.7 (9.6) 2.3 (8.9)
Abbreviations: EPIC¼Expanded Prostate Cancer Index Composite; MCS¼Mental Component Summary; PCS¼Physical Component Summary; QoL¼quality of life; SF-12¼Short-form-12.
aHigher scores indicating better QoL. Note: SF-12 is standardised to the population normative values of the United States of America , with a mean score of 50 and a s.d. of 10.
bCohen’s d effect size¼group mean differences at patients post intervention divided by mean s.d.
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Figure 3. Box-plot median urinary irritative sum-score post
intervention in a randomised rehabilitation study with 161 participants
with PCa, Odens, Denmark. The whiskers show the lower/upper
adjacent value and the box shows 25th–75th percentile. The dots show
outliers.
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concurrently (P¼ 0.001), 31.3–24.7 mV in the intervention group
and 31.6–23.3 mV in the control group, with no significant
differences between the two groups. At post intervention in the
overall population, a significant correlation was found between
muscle strength measured by digital evaluation and EMG
(r¼ 0.5698, Po0.001).
In the intervention group compared with the control group, the
urinary irritative sum-score improved in patients with impaired
o5 pelvic floor strength at pre-intervention Modified Oxford
Scale, (7.4 point, d¼ 0.51; P¼ 0.012) as did the urinary irritative
sum-score in patients with low EMG at pre-intervention,o21 mV
(9.2 point, d¼ 0.63; P¼ 0.012).
In the digital evaluation, inter-rater reliability among the three
assessors had Kappa values of 0.72, 0.83, and 0.84.
The time used for the intervention for each patient was
estimated to 4 h including time for documentation.
DISCUSSION
We found that the multidisciplinary rehabilitation had a significant
effect compared with usual care on the primary outcome: urinary
irritative symptoms, among a large sample of irradiated PCa
patients. As secondary outcomes, we observed benefits of the
intervention in improvement in overall urinary and hormonal
symptoms, and physical QoL. Our intervention improved urinary
irritative symptoms by4 5 points on a 0–100 scale compared with
a control group, which is considered clinically significant (Osoba
et al, 1998). The clinical meaningfulness was furthermore
confirmed by the patients as they experienced the intervention
useful in everyday life, as stated in focus groups (Dieperink et al,
2013).
Consistent with our finding, Faithfull et al (2011) in a small
phase II trial including 22 irradiated patients observed significant
improvements, with a median score change of 5, on lower urinary
tract symptoms following an intervention consisting of a
programme almost the same as used in this study (self-manage-
ment programme comprising pelvic floor exercises, bladder
training, patient education, and problem solving). However,
Faithfull et al (2011) included only patients with moderate-
to-severe symptoms, and their pelvic floor exercises were conducted
as group sessions, whereas we included all patients with an
individualised intervention aiming at the targeted and exact need
of each individual patient. Our results are parallel to those from
two randomised studies (N¼ 102 and 300) among PCa patients
treated with prostatectomy using a single component pelvic floor
exercise programme to improve incontinence (Van Kampen et al,
2000; Filocamo et al, 2005). Ribeiro et al (2010) found in a
controlled study in prostatectomy patients a positive effect of pelvic
floor muscle training and biofeedback. They concluded that
training improved not only recovery of urinary incontinence but
also voiding symptoms and pelvic floor muscle strength. Ribeiro
et al (2010) also included an extensive review and discussion of the
available studies on prostatectomy patients. They described how a
more precise comparison of the studies was difficult because of
methodological differences among these. As the two treatments of
PCa, prostatectomy, or radiotherapy have different adverse effects,
a direct comparison with our data is even more difficult.
Pelvic floor function is closely related to bladder capacity or
voiding dysfunction.
Previous research has examined pelvic floor muscle strength in
men treated with prostatectomy, but there is no gold standard of
measurement (Messelink et al, 2005). The pelvic floor strength
measured by digital evaluation was stable during the period, but as
measured by EMG, the pelvic floor strength declined significantly.
Thus, EMG may be more sensitive in detecting changes in muscle
strength, although the signals from the surface EMG must be made
with caution owing to the risk of cross talk from other muscles
(Herrington, 1996). Furthermore, studies show that ADT may
cause a decline in large muscle groups (Williams et al, 2005;
Alibhai et al, 2010), and perhaps this includes the muscles of the
pelvic floor. Hence, the self-reported urinary improvements were
in some contradiction to the clinical measurements of the pelvic
floor, as the pelvic floor strength was stable as judged by repeated
digital evaluation and declined as judged by EMG. Therefore, no
clearcut causal relationship between the subjective dimensions of
QoL and the objective measurements of the pelvic floor were seen.
Pelvic floor muscle strength must be of some importance for the
urinary irritative sum-score, as the intervention improved urinary
irritative sum-score especially in patients with impaired muscle
strength after radiotherapy. However, the exact relationship
between the pelvic floor function and urinary irritative symptoms
are still to be investigated. As this is the first study that investigates
Table 4. Pelvic floor muscle strength in prostate cancer patients treated with radiotherapy in RePCa: a randomised controlled rehabilitation study
Pelvic floor muscle strength Intervention group, n¼79 Control group, n¼82
Mean (95%CI)
Study population
pre-radiation Pre-intervention Post intervention Pre-intervention Post intervention P-valuea
No. of participants n¼ 156 n¼ 73 n¼68 n¼ 75 n¼ 71
Digital evaluationb 4.0 (3.8;4.1) 3.8 (3.5;4.0) 3.9 (3.6;4.1) 3.8 (3.6;4.1) 3.7 (3.5;4.0) NS
Static strength no. of seconds to hold
one contraction
34.4 (31.1;37.7) 35.2 (30.2;40.2) 36.1 (31.0;41.2) 31.6 (26.6;36.6) 32.9 (28.0;37.8) NS
Dynamic strength no. of contractions
during 60 s
22.2 (19.9;24.5) 21.2 (17.7;24.7) 22.7 (18.9;26.5) 19.1 (15.9;22.3) 19.2 (15.9;22.6) NS
No. of participants n¼ 156 n¼ 72 n¼66 n¼ 71 n¼ 71
EMG average activity (mV) 38.2 (34.8;41.6) 31.3 (27.9;34.8) 24.7 (21.7;27.7) 31.6 (27.3;35.9) 23.3 (20.4;26.2) NS
EMG average rest (mV) 6.8 (6.2;7.5) 5.8 (5.0;6.6) 4.8 (4.0;5.5) 5.5 (4.9;6.1) 4.9 (3.6;6.2) NS
Abbreviations: CI¼ class interval; EMG¼ electromyography.
aPost-intervention differences between groups. Wilcoxon Sign-rank test. Reported P-values are two-sided and Po0.05 was considered statistically significant.
bMeasured by Modified Oxford Scale 0–6.
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the pelvic floor in PCa patients treated with radiotherapy, it
remains to be seen whether the finding can be reproduced in future
studies.
The patients in the control group met the blinded assessors only
when being tested. However, patients were able to obtain
information from the internet or elsewhere, and this may, in
theory, have watered down the intervention. Pelvic floor exercises
are difficult to learn without instructions (Messelink et al, 2005),
and consequently, we offered the intervention group meticulous
instructions in order to give the best opportunity to counteract
adverse effects, which may have been superior to information from
other sources, for example, the internet.
Our recently published cross-sectional survey including 317 PCa
patients (Dieperink et al, 2012) showed that risk factors (for
example, smoking, severe obesity BMI 430, and the condition of
living alone) were associated with increased risk of late adverse
effects after radiotherapy. The present study showed that patients
living alone had a better outcome after intervention. These results
imply a need for integration of not only the adverse effects but also
personal factors as lifestyle and life conditions during intervention.
Screening before intervention may identify patients with a
potential for improvement and the motivation to make an effort.
The present study showed that patients with pre-intervention
objective (i.e., digital evaluation o5 or EMGo21) or subjective
(i.e., EPIC irritative sum-score below 68 points) impairment
improved the most. Therefore, screening with these measures may
be considered in future rehabilitation intervention studies.
This study has a number of advantages. The accrual procedures
made it possible to obtain information about the majority of the
patients who denied participation, as 41 out of 48 filled out
questionnaires before radiotherapy. This group of patients differed
from patients included in the randomisation by having
a statistically significant, but marginally lower D’Amico risk.
We find it unlikely that it was related with not joining the study.
In addition, this group included more patients living alone, and
they had a lower but not significant level of education and
higher incidence of smoking than did the randomised patients.
Taken together, these factors should be taken into account if the
intervention tested in this study is used as a standard of care (Holm
et al, 2013), and health care professionals should make special
efforts to include these groups in rehabilitation studies. Internal
validity was maintained because of the randomisation and the
homogeneity of the groups. The study provided good feasibility
with a high inclusion rate and few drop-outs, although one
important limitation was that we did not monitor the patients’
compliance to the recommended self-training home exercises.
In future studies, monitoring has to be considered at least with
patient-reported outcomes, for example, exercise logbooks.
Although we have the calculated time consumption used for the
intervention, we did not make an exact cost-effectiveness analysis,
but this could be recommended in future studies. Another
limitation was that the design including psychosocial support
and physical instructions do not allow blinding as a possibility.
Instead, a trusting relation between patients and professionals is
considered as an important motivation and may influence patient-
reported outcome. Owing to concerns about the impact of
radiotherapy on the pelvic floor muscles, the intervention started
1 month after radiotherapy, although we are aware of the
recommendation that rehabilitation is started at diagnosis. Some
of the patients complained of rectal tenderness when pelvic floor
strength was tested, and this indicates that this was a correct
decision. However, the intervention did not have any negative
effects on the outcomes measured, and only few patients dropped
out. The relative unrestricted inclusion and exclusion criteria, the
uniform treatment protocol, and the fact that men who attended
the study were living in cities as well as in rural areas in Denmark,
allow generalisation of the results because the study sample was
representative of a population of irradiated PCa patients. However,
only one patient included in the study was not an ethnic Dane, and
this limits the generalisation from the findings into a broader
context. Furthermore, the design permits only causal conclusions
about the combined programme of nursing and physical therapy
counselling and not about the components separately.
Based on the results of this study, it can be recommended that
patients treated with radiotherapy of the prostate may be offered a
combined nurse–physiotherapist intervention programme, espe-
cially patients with impairments within urinary irritative function.
Timing, duration, and more focus on the empowerment aspects of
this intervention need further study.
ACKNOWLEDGEMENTS
We owe special thanks to the cancer patients who participated in
the study for their valuable contributions. We are indebted to all
colleagues who took part in the study. The study was supported by
the Odense University Hospital (OUH) Research Foundation, the
University of Southern Denmark, the Danish Cancer Society,
CIRRO – the Lundbeck Foundation Center for Interventional
Research in Radiation Oncology, the Department of Oncology,
OUH, the Mette Hede Nielsen Foundation, the Danish
Nurses Organization Research Foundation, and the Propa Vita
Foundation.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
REFERENCES
Alibhai SM, Breunis H, Timilshina N, Johnston C, Tomlinson G, Tannock I,
Krahn M, Fleshner NE, Warde P, Canning SD, Klotz L, Naglie G (2010)
Impact of androgen-deprivation therapy on physical function and
quality of life in men with nonmetastatic prostate cancer. J Clin Oncol 28:
5038–5045.
Armes J, Crowe M, Colbourne L, Morgan H, Murrells T, Oakley C, Palmer N,
Ream E, Young A, Richardson A (2009) Patients’ supportive care needs
beyond the end of cancer treatment: a prospective, longitudinal survey.
J Clin Oncol 27: 6172–6179.
Benner P, Wrubel J (1989) The Primacy of Caring. Stress and Coping in Health
and Illness. Addison-Wesley Publishing Company.
Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P (2008) Extending the
CONSORT statement to randomized trials of nonpharmacologic
treatment: explanation and elaboration. Ann Intern Med 148: 295–309.
Budaus L, Bolla M, Bossi A, Cozzarini C, Crook J, Widmark A, Wiegel T
(2012) Functional outcomes and complications following radiation
therapy for prostate cancer: a critical analysis of the literature. Eur Urol 61:
112–127.
Cockle-Hearne J, Faithfull S (2010) Self-management for men surviving
prostate cancer: a review of behavioural and psychosocial interventions
to understand what strategies can work, for whom and in what
circumstances. Psychooncology 19: 909–922.
D’amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K,
Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A
(1998) Biochemical outcome after radical prostatectomy, external beam
radiation therapy, or interstitial radiation therapy for clinically localized
prostate cancer. JAMA 280: 969–974.
Dieperink KB, Hansen S, Wagner L, Johansen C, Andersen KK, Hansen O
(2012) Living alone, obesity and smoking: important factors for quality of
life after radiotherapy and androgen deprivation therapy for prostate
cancer. Acta Oncol 51: 722–729.
Dieperink KB, Wagner L, Hansen S, Hansen O (2013) Embracing life after
prostate cancer. A male perspective on treatment and rehabilitation.
Eur J Cancer Care 22: 549–558.
BRITISH JOURNAL OF CANCER Rehabilitation after radiotherapy for prostate cancer
3012 www.bjcancer.com |DOI:10.1038/bjc.2013.679
Dorey G (2006) Pelvic Dysfunction in Men. Diagnosis and Treatment of Male
Incontinence and Erectile Dysfunction. John Wiley & Sons Ltd: United
Kingdom.
Dorey G (2007) A clinical overview of the treatment of post-prostatectomy
incontinence. Br J Nurs 16: 1194–1199.
Faithfull S, Cockle-Hearne J, Khoo V (2011) Self-management after prostate
cancer treatment: evaluating the feasibility of providing a cognitive and
behavioural programme for lower urinary tract symptoms. BJU Int 107:
783–790.
Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of
cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:
765–781.
Filocamo MT, Li Marzi V, Del Popolo G, Cecconi F, Marzocco M, Tosto A,
Nicita G (2005) Effectiveness of early pelvic floor rehabilitation treatment
for post-prostatectomy incontinence. Eur Urol 48: 734–738.
Grise P, Thurman S (2001) Urinary incontinence following treatment of
localized prostate cancer. Cancer Control 8: 532–539.
Herrington L (1996) EMG Biofeedback: What can it actually show?
Physiotherapy 82: 581–583.
Holm LV, Hansen DG, Larsen PV, Johansen C, Vedsted P, Bergholdt SH,
Kragstrup J, Sondergaard J (2013) Social inequality in cancer
rehabilitation: A population-based cohort study. Acta Oncol 52: 410–422.
Johansen C (2007) Rehabilitation of cancer patients—research perspectives.
Acta Oncol. 46: 441–445.
King DW, Lashley R (2000) A quantifiable alternative to double data entry.
Control Clin.Trials 21: 94–102.
Messelink B, Benson T, Berghmans B, Bo K, Corcos J, Fowler C, Laycock J,
Lim PH, Van Lunsen R, A Nijeholt GL, Pemberton J, Wang A, Watier A,
Van Kerrebroeck P (2005) Standardization of terminology of pelvic floor
muscle function and dysfunction: report from the pelvic floor clinical
assessment group of the International Continence Society. Neurourol
Urodyn 24: 374–380.
Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR
(2008) Management of complications of prostate cancer treatment.
CA Cancer J Clin 58: 196–213.
Michigan UO (2012) EPIC Prostate Cancer Index Composite—sample size -
http://www.med.umich.edu/urology/research/epic.html.
Miller DC, Sanda MG, Dunn RL, Montie JE, Pimentel H, Sandler HM,
Mclaughlin WP, Wei JT (2005) Long-term outcomes among localized
prostate cancer survivors: health-related quality-of-life changes after
radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol
23: 2772–2780.
Miller WR, Rollnick S (2002) Motivational Interviewing, Preparing People to
Change Addictive Behavior. The Guildford Press: NY, USA.
Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the
significance of changes in health-related quality-of-life scores. J Clin Oncol
16: 139–144.
Rehabiliteringsforum (2004) Hvidbog om rehabiliteringsbegrebet. Marselisborg
Centret: Denmark.
Ribeiro LH, Prota C, Gomes CM, De Bessa Jr. J, Boldarine MP, Dall’oglio MF,
Bruschini H, Srougi M (2010) Long-term effect of early postoperative
pelvic floor biofeedback on continence in men undergoing radical
prostatectomy: a prospective, randomized, controlled trial. J Urol 184:
1034–1039.
Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L,
Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E,
Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N,
Wo Shah WJ (2008) Quality of life and satisfaction with outcome
among prostate-cancer survivors. New Engl J Med 358: 1250–1261.
Szymanski KM, Wei JT, Dunn RL, Sanda MG (2010) Development and
validation of an abbreviated version of the expanded prostate cancer index
composite instrument for measuring health-related quality of life among
prostate cancer survivors. Urology 76: 1245–1250.
Van Kampen M, De Weerdt W, Van Poppel H, De Ridder D, Feys H,
Baert L (2000) Effect of pelvic-floor re-education on duration and degree
of incontinence after radical prostatectomy: a randomised controlled trial.
Lancet 355: 98–102.
Ware Jr J, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey:
construction of scales and preliminary tests of reliability and validity. Med
Care 34: 220–233.
Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG (2000) Development
and validation of the expanded prostate cancer index composite (EPIC)
for comprehensive assessment of health-related quality of life in men with
prostate cancer. Urology 56: 899–905.
Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P,
Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fossa SD (2009) Endocrine
treatment, with or without radiotherapy, in locally advanced prostate
cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 373:
301–308.
Williams MB, Hernandez J, Thompson I (2005) Luteinizing hormone-
releasing hormone agonist effects on skeletal muscle: how hormonal
therapy in prostate cancer affects muscular strength. J Urol 173:
1067–1071.
World Health Organization, W.H.O (2012) RE: World Health Organization
WHO. Definition of rehabilitation http://www.who.int/topics/
rehabilitation.
Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A,
Amols HI (2008) Incidence of late rectal and urinary toxicities after
three-dimensional conformal radiotherapy and intensity-modulated
radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70:
1124–1129.
This work is published under the standard license to publish agree-
ment. After 12 months the work will become freely available and
the license terms will switch to a Creative Commons Attribution-
NonCommercial-Share Alike 3.0 Unported License.
Rehabilitation after radiotherapy for prostate cancer BRITISH JOURNAL OF CANCER
www.bjcancer.com |DOI:10.1038/bjc.2013.679 3013
